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Renal handling of calcium and phosphate during mineralocorti-
coid "escape" in man. Previous work in animals and man sug-
gests a close relationship between sodium and phosphate reab-
sorption in proximal tubule, and between sodium and calcium
in the proximal tubule and the distal nephron; hence, decreased
sodium transport in the proximal tubule may be associated with
phosphaturia since phosphate is mostly unreabsorbed distally,
while decreased sodium reabsorption in the distal tubules may
occur with calciuria only. The sites and the renal mechanisms
of mineralocorticoid "escape" were studied by Na, Ca and P
balance and clearance methods in seven patients with primary
aldosteronism (aldos) and in three normal subjects. In both
groups, when Na intake was raised or lowered over a range of
20 to 200 mEq/day, Ca clearance (Ca) varied with CNa (r = 0.8,
P<0.00l); but ACCaIACNa was higher (P<0.0l) in the patients
with aldosteronism (1.6) compared to normals (0.64). On daily
intake of 20 mEq Na, Cca was not different in the two groups,
whereas at dietary Na of 200 mEq, Ca was higher (P<0.001)
in the patients (1.80 mI/mm) than in normals (1.07 mI/mm),
whereas CNa was similar in the two groups. In contrast to Ca,
C did not vary with CNa in either group at any level of Na
intake. Data suggest: 1) renal adjustments to dietary Na occur
mainly in the distal nephron in both groups, since changes in
CNa were accompanied by changes in Ca but not C; 2) aldo-
sterone "escape" occurs with hypercalciuria and results from
decreased distal reabsorption at sites (insensitive to aldosterone)
where Na and Ca are closely linked; 3) in normal subjects, distal
tubular sodium adjustments occur at both the latter site and an
aldo-sensitive site where Na and Ca are not linked.
Comportement renal du calcium et du phosphate au cours de
l'échappement a l'action des minéralocorticoides. Les travaux
antérieurs chez l'animal et l'homme suggérent une relation
étroite entre les réabsorptions du sodium et du phosphate dans
Ic tube proximal et entre celles du sodium et du calcium dans le
tube proximal et Ia partie distale du nephron. Ainsi une diminu-
tion du transfert du sodium dans le tube proximal peut être
associée a une phosphaturie du fait que le phosphate n'est pas
réabsorbd par les regions distales alors qu'une diminution de la
reabsorption distale du sodium peut n'être accompagnée que
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d'une calciurie. Les sites et les mécanismes rénaux de l'échappe-
ment aux minéralocorticoides ont été étudiés aux moyens des
bilans et des clearances de Na, Ca et P chez sept malades atteints
d'hyperaldostéronisme primaire et chez trois sujets normaux.
Dans les deux groupes, quand l'apport de Na était augmenté ou
diminué au-delà de l'éventail des valeurs de 20 a 200 mEq/jour,
la clearance de Ca (Cca) variait avec CNa (r= 0.8; P<0.001)
mais CCa/CNa était supérieur (P<0.01) chez les malades atteints
d'hyperaldosteronisme par comparaison avec les sujets normaux
(0.64). Avec un apport de sodium de 20 mEq/jour, Ca n'était
pas difféfent dans les deux groupes alors qu'avec un apport de
200 mEq/jour Cc, était plus grand (P<0.0O1) chez les malades
(1.80 mI/mm) que chez les normaux (1.07 mI/mm) alors que CNa
était semblable dans les deux groupes. A l'opposé C ne variait
avec CNa dans aucun des groupes quelque soit l'apport de Na.
Les résultats suggèrent que: 1) les ajustements rénaux a l'apport
de Na surviennent principalement dans le néphron distal dans
les deux groupes puisque les variations de CNa ont été accom-
pagnés par des modifications de Ce,, mais non de C; 2) l'échap-
pement a l'aldostérone et accompagné d'une hyper calciurie et
résulte d'une diminution de la reabsorption distale par des sites
(insensibles a l'aldostérone) oü Na et Ca sont étroitenient lies;
3) chez les sujets normaux les ajustements distaux du sodium ont
lieu a la lois aux sites ci-dessus mentionnés et aux sites sensibles
a l'aldostérone oü Na et Ca ne sont pas lies.
Patients with hypermineralocorticoidism and normal sub-
jects given aldosterone or deoxycorticosterone acetate retain
sodium only transiently and "escape" from the salt re-
taining effect of these hormones by establishment of a new
sodium equilibrium [1—3]. The modes and loci of the intra-
renal adjustments in sodium transport associated with this
"escape" phenomenon have not been elucidated. Earlier
micropuncture experiments attempting to study this prob-
lem concluded that inhibition of sodium reabsorption in
the proximal tubule occurred during "escape" [4]; however
more recent data in DOCA "escaped" dogs have indicated
that the distal nephron might be the major site of adjust-
ment [5]. In an attempt to define the sites of intrarenal
adjustments associated with changes in dietary sodium
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intake in man with mineralocorticoid excess we have
studied the relationships between sodium, calcium and
phosphate excretion in patients with primary hyper-
aldosteronism and in normal subjects, utilizing metabolic
balance and clearance techniques.
The rationale for the experimental design of these studies
is as follows: since the bulk of filtered phosphate is reab-
sorbed proximally [6—11] whereas filtered calcium is reab-
sorbed both proximally and distally [121, maneuvers which
inhibit sodium transport mainly in the proximal tubule
(such as administration of acetazolamide [13]) tend to be
markedly phosphaturic while only moderstely natriuretic
and minimally calciuric [14]. On the other hand, procedures
which primarily inhibit sodium transport in the distal
nephron (such as ethacrynic acid or furosemide administra-
tion [15]) are natriuretic, calciuric and only minimally
phosphaturic [13, 16]. Therefore changes in urinary phos-
phate tend to reflect alterations in the proximal handling
of sodium while fluctuations in the urinary calcium, if as-
sociated with no significant change in phosphate excretion,
may primarily reflect fluctuations in the distal handling of
sodium. If the proximal tubule plays a major role in
mineralocorticoid "escape", phosphaturia would be ex-
pected to accompany the increase in sodium excretion.
However if "escape" occurs primarily in the distal nephron,
natriuresis and calciuria might occur without a parallel rise
in phosphate excretion.
Methods
Seven patients with primary hyperaldosteronism four
females and three males), 30 to 54 years of age, and three
normal subjects (all males) between 24 and 28 years of age
were studied in the Clinical Research Center with the use
of standard metabolic balance techniques. Four patients
(J.F., D.B., J.G., and T.N.) had solitary cortical adenomata
at surgical exploration and one patient (E.J.) had bilateral
adrenal hyperplasia. Two patients (D.W. and A.B.) refused
surgery; however these two patients (as well as all the other
patients) satisfied the usual criteria for the diagnosis in-
cluding hypokalemic metabolic alkalosis, persistently low
plasma renin levels, elevated aldosterone secretory rates
and an appropriate response to spironolactone.
After a minimum of three days of dietary adjustments,
all subjects were begun on a constant diet. This diet for
each individual was continued throughout the study except
for the addition of sodium as weighed sodium chloride
capsules during the moderate or high sodium intake period.
Dietary potassium was maintained constant at approxi-
mately 75 mEq/day. Dietary calcium ranged between 200
and 600 mg/day and dietary phosphate ranged from 500
to 1100 mg/day, but was kept constant for each subject.
There was no correlation between dietary intake of calcium
and urinary calcium excretion; however, subjects on higher
phosphate intakes had somewhat higher values for urinary
phosphate exeretion. The range for the dietary intake of
calcium and phosphate was the same for both groups. An
attempt was made to maintain each subject on an isocaloric
intake.
The first dietary period (Period I) consisted of at least
five days of a low sodium intake (between 7 and 12 mEq/
day) followed by the second period (Period II) of a high
sodium intake (between 180 and 240 mhq/day). Period II
was continued for five days or until "escape" had occurred;
"escape" was defined as a period of weight stabilization or
loss after an initial period of weight gain. This closely
correlated with the stabilization of sodium excretion. Four
patients (J.F., D.B., D.W., and A.B.) were also studied on
a moderate sodium intake (120 mEq/day) for five to seven
days which was interposed between the low and high so-
dium dietary periods.
Twenty-four hour urines were collected daily from all
subjects. All of the controls and three of the patients (T.N.,
J.G., and E.J.) had stool collections as well. Blood, urine,
stool and dietary specimens were analyzed for sodium,
potassium, creatinine and phosphate by methods pre-
viously reported from this laboratory [16]. Diets and stools
were analyzed following digestion with concentrated nitric
acid. Calcium measurements were carried out either by
atomic absorption spectrophotometry (Perkin-Elmer) or by
a fluorometric method involving titration of a calcium-
calcein complex with ethylenediaminetetracetic acid
(EDTA) [17]. Endogenous creatinine clearance was used
as an index of glomerular filtration rate and clearances of
other ions were calculated appropriately. Calcium clear-
ances were calculated on the basis of total serum calcium
concentration rather than values for diffusible or ultra-
filterable calcium.
The data for the last three days of each period were
averaged and were compared for: a) significant differences
between groups, and b) significant differences between
different dietary periods for each given group by t-test for
unpaired and paired variables, respectively [18]. Two pa-
tients (A.B. and D.W.) were on a slightly higher sodium
intake (70 and 40 mEq/day) during the low sodium period
than the other subjects. Their data are analyzed separately
as well as with the whole group.
Results
Representative metabolic balance studies. Figs. 1 and 2
summarize the observations in a normal control subject
(K.M.) and in a patient (E.J.) Each subject achieved sodium
balance during both dietary periods. The course of adjust-
ment to low sodium intake cannot be strictly compared
since this period always followed three days of adjustment
during which sodium intake was gradually lowered. Ad-
justment to the high sodium intake occurred by the third
day in the control subject and by the fourth day in the
patient. Part of the initial weight loss in this patient
(E.J.) was caloric in nature.
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Relationship between urinary excretion, clearance, and
fractional excretion of sodium and calcium. I) Low Sodium
Diet: All subjects were able to lower their urinary sodium
excretion to the level of dietary intake. The mean values
for sodium and calcium excretion rates and clearances were
not significantly different between the control subjects and
the patients during the low sodium dietary period (24 hr
sodium excretion 29 22 mEq in the patients vs. 12 4mEq
in the controls, and sodium clearance 0.14±0.lOml/min
in the patients vs. 0.06 0.03 ml/min in the controls; 24 hr
urinary calcium excretion 100±36mg in the patients vs.
73±24mg in the controls; and calcium clearance
0.76 mi/mm in the patients and 0.52± 0.17 mi/mm
in controls; see Table 1). The tendency for the patients to
have a slightly higher mean calcium excretion than the
control subjects, nicely parallels the same tendency in mean
sodium excretion. This is due to the higher sodium intake
in two patients (A.B. and D.W.) who were on 70 and
40 mEq of sodium per day during Period I. If these two
patients are excluded, urinary excretion and clearance of
sodium and calcium during this period become quite similar
in both groups (Table 2).
II) High Sodium Diet: Serum values of sodium, potas-
sium, calcium and phosphate remained stable in both
groups during the transition from low to high sodium
intake. The serum sodium level was significantly higher and
the serum potassium level significantly lower in the patients
compared to the control subjects, and did not change with
sodium loading. Creatinine clearance remained stable in
the control group (128 9 to 139 23 mi/mm); however, it
increased significantly in the patient group (88 18 to
102±l5ml/min. P.cz0.02, Table 1).
The mean urinary sodium excretion and clearance were
190 mEq/day and 0.91 0.07 mI/mm, respectively, in
the patients. This was similar to the excretion rate of
184±25 mEq/day and a clearance of 0.84 mi/mm in
the control group. Mean calcium excretion increased to
252±36mg/day with a clearance of 1.80±0.44ml/min in
the patients and 145 4 mg/day and 1.07 0.30 ml/min in
the control group. The difference in calcium excretion and
clearance between the patients and the controls on high
sodium intake was significant. (P<0.02, Table 1). If the
two patients with higher baseline sodium intake (A.B. and
D.W.) are excluded, the mean calcium excretion rate and
clearance on high sodium intake in the patient group re-
mains statistically greater than in the control group
(P<0.05, Table 2).
A summary of the change in fractional excretion of
sodium (CNa/CCr) and calcium (Ca/Ccr) between dietary
periods I and II is given in Fig. 3. The changes in CNa/CCa
are similar in both groups. In contrast, each patient ex-
hibited a rise in CCa/Ccrthat was greater than the change in
any of the controls.
Fig. 4 shows the relationship between calcium and
sodium clearance in the patients and control subjects. We
have utilized all the appropriate values obtained throughout
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Fig. 1. Representative balance studies in a normal subject (K.M.)
and a patient with primary aldosteronism (E.J.): Data on sodium
and calcium metabolism. See text for details.
Calcium excretion followed sodium excretion closely in
both subjects, however the patient with hyperaldosteronism
had a more marked increase in urinary calcium excretion
in response to the increase in the dietary sodium than the
normal subject. Stool as well as urinary phosphate did not
change significantly in either subject in response to the
increase in sodium intake. Urinary potassium remained
stable in the control subject while it rose in the patient
during sodium loading (Fig. 2).
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Fig. 2. Representative balance studies in a normal subject (KM.)
and a patient with primary aldosteronism (E.J.): Data on phos-
phate and potassium metabolism. See text for details.
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Low Na High Na Low Na
Diet Diet Diet
15.0 15.0
10.0 10.0
High Na Table 2. Twenty-four hour urinary excretion rates and clearances
Diet of sodium and calcium in controls and from patients who had
comparable rates of sodium excretiona
2.0
1.5
0.5
0.0
Twenty-four hour Clearance
Diet urinary excretion
period Sodium Calcium Sodium Calcium
mEq/24 hr mg/24 hr mi/mm mi/mm
A. Controls
lb 12± 4 73±24 0.06±0.08 0.52±0.17
JIb 184±25 145±42 0.84±0.14 1.07±0.30
B. Hyperaldosteronismc
I 19± 7 77±15 0.09±0.04 0.58±0.11
II 199±18 240± 33d 0.93±0.07 l.87±O.28d
Controls
0C
x
L) 5.0 5.0
a
2.0
1.0
1.5 1.5
1.0 1.0
0.5 0.5
0.0 0.0
Hyperaldosteronism
Fig. 3. Changes in fractional excretion of sodium, calcium and
phosphate associated with increase in dietary intake of sodium in
controls and patients with primary aldosteronism. Each point was
obtained by subtracting the mean values of the last three days of
low sodium intake period from the mean value of the last three
days of high sodium dietary period.
2.8
2.4
2.0
1.6
c)U
0.8
0.4
e Hyperaldosteronism
• Controls
e
e
0
e
0e 0
a All values are mean SD
b 1= low sodium dietary period; II =high sodium dietary period.
o Four patients were: J.F., D.B., J.G., and E.J.
U Indicates significant difference from control group on similar
high sodium diets at P<0.05.
the study in each subject. Two separate regression lines are
obtained which are best defined by the following equations:
Patients: Cca =0.54 + 1.6 CNa (r =0.81, P <0.001); Con-
trols: Cca=O.48+O.64 CNa (r=0.75, P<0.OOl). These
two lines are non-parallel by analysis of covariance
(P.<0.001). On low sodium intake the lines converge and
Cca is not different in the two groups.
Relationship between mean urinary excretion, clearance
and fractional excretion of sodium and phosphate. Despite
some variation in mean phosphate excretion and clearance
between individual subjects, the means for the two groups
were not significantly different (Table 1). In both groups
the urinary phosphate excretion and clearance did not
change significantly with sodium loading. Phosphate clear-
ance was somewhat higher in the patient group on either
diet; however this difference is not significant.
Changes in fractional excretion of phosphate (CpICcr)
secondary to the increase in sodium intake are summarized
in Fig. 3. There was only minimal and variable change in
all control subjects and in five out of the seven patients.
One patient exhibited an increase and one patient had a
large decrease in Cp/Ccr. These data, therefore, fail to show
a significant change in phosphate excretion with alterations
in sodium balance.
Discussion
These data show a clear separation between renal handling
of calcium and phosphate during chronic sodium loading
in both normal subjects and patients with primary hyper-
aldosteronism. Mean phosphate excretion was comparable
in both groups and did not change with sodium loading in
either group. In contrast, alterations in sodium intake were
associated with parallel changes in calcium excretion in
• S
•
0.2 0.4 0.8
CN, mi/mm
Fig. 4. Relationship between calcium clearance (Cca) and sodium
clearance (CNO) in patients with primary hyperaldosteronism and
normal controls during adjustments to variations in dietary sodium
intake. See text for details.
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both groups. Furthermore, patients with primary hyper-
aldosteronism showed significantly greater hypercalciuria
on high sodium intake than the control group. The dif-
ference in calcium excretion between patients and normal
controls was not present on low sodium intake.
Micropuncture studies in rats [7—9] and dogs [6] have
shown that the bulk of phosphate reabsorption occurs in
the proximal tubule. Tracer microinjection studies in rats
[10] have indicated that injection of phosphate in physio-
logical concentration in the most distal segments of the
accessible proximal tubule is associated with greater than
90% recovery and injection in the early distal convoluted
tubule with 100% recovery of radio-labelled phosphate [10].
Furthermore microperfusion studies of the loop of Henle
indicate little or no phosphate reabsorption in this seg-
ment [11]. These observations, therefore, indicate that
proximal inhibition of phosphate reabsorption closely
parallels increases in phosphate excretion because of the
limited capacity of the entire distal nephron to transport
phosphate. Clearance studies have shown that phosphaturia
results from maneuvers which seem to inhibit primarily
proximal tubular sodium reabsorption such as acetazol-
amide and moderate saline loading [14, 19]. Micropuncture
experiments have revealed that inhibition of proximal
tubular phosphate reabsorption characteristically ac-
companies inhibition of sodium and fluid reabsorption
[6, 9]. Therefore, since most of the sodium rejected in the
proximal tubule is reabsorbed distally [20], in contrast to
phosphate, changes in phosphate excretion tend to parallel
closely the alterations in proximal tubular sodium reab-
sorption.
Calcium reabsorption occurs in both the proximal and
the distal nephron and generally parallels sodium reab-
sorption [12]. This parallelism is maintained despite changes
in glomerular filtration rate and renal blood flow and it
occurs with acute saline loading [21]. Procedures which
primarily inhibit proximal reabsorption of sodium, such
as acetazolamide [141 and hyperoncotic albumin [22] are
only moderately natriuretic and minimally calciuric [14, 23].
In contrast, agents which have a major action in the distal
nephron, such as ethacrynic acid or furosemide [15] pro-
duce a marked increase in calcium excretion [14, 161.
Therefore, although increases in calcium excretion could
result from inhibition of calcium (with sodium) either
proximally or distally, the above observations suggest that
the increase in calcium excretion would parallel more
closely distal inhibition rather than proximal changes. This
contention would be strengthened further if increases in
sodium and calcium excretion were not accompanied by
phosphaturia.
Based on the above discussion, our data showing parallel
increases in sodium and calcium excretion without changes
in urinary phosphate, would suggest that the distal nephron
is the primary site of adjustment to variation in sodium
intake in both patients with excess mineralocorticoids and
normal subjects. This interpretation is compatible with the
micropuncture studies of Knox et a! [5] who found no dif-
ference in the delivery of fluid out of the proximal tubule
in DOCA "escaped" dogs compared to the normal dogs.
It is, of course, possible that a small degree of proximal
tubular inhibition might have occurred during mineralo-
corticoid escape in our studies, unassociated with a phos-
phaturia. This possibility exists because the distal nephron
might possess a small but finite capacity to reabsorb a
modest increase in the phosphate load delivered from the
proximal tubule. This phenomenon alone, however, cannot
be the major cause of the rise in sodium excretion during
"escape", because it has been well documented that modest
increases in distal delivery of sodium are not natiuretic
unless the distal nephron is also inhibited [20, 23].
The precise mechanism responsible for the proposed
alterations in distal sodium reabsorption in the sodium
loaded subjects are unknown. Buckalew and Lancaster [24]
and Sealey, Krishman and Laragh [25] have reported the
presence of a natriuretic factor in the blood of DOCA
"escaped" dogs and patients with primary hyperaldo-
steronism respectively. Both of these groups of investigators
have proposed that this natriuretic hormone has its major
effects in the distal nephron. While our experiments provide
no specific information on this hormone, the observations
are compatible with increased levels of such a factor in-
fluencing distal sodium transport.
The hypercalciuria noted in our patients with primary
hyperaldosteronism during sodium loading extends similar
observations made in dogs and rats [26, 27] to man. The
stimulus for this hypercalciuria is not known, however
several factors including hypertension, mineralocorticoid
hormones and/or volume expansion should be considered.
Although the role of elevated blood pressure has not been
studied in man, animal stuides have shown that hyper-
calciuria occurs in normotensive DOCA-loaded dogs [26]
and rats [27] on high sodium intake. Furthermore acute
administration of mineralocorticoid hormones to man [28]
or chronic administration to rats on low sodium diet [27] is
not associated with hypercalciuria, indicating that positive
sodium balance and volume expansion are required for
manifestation of the hypercalciuria. These observations
also reveal that mineralocorticoid hormones per se are not
responsible for the observed hypercalciuria.
Our data show that the rate of rise in calcium excretion
as a function of sodium excretion was significantly greater
in the patient group than the controls. In fact at low levels
of dietary sodium, calcium excretion in the normal subjects
and in patients with hyperaldosteronism was similar, the
hypercalciuria in the latter group developing only with
sodium loading. The explanation for this may lie in the fact
that subjects with hyperaldosteronism have an obligatory
sodium reabsorption at nephron sites sensitive to aldo-
sterone even during high sodium intake. Therefore to
achieve sodium balance more sodium must be rejected at
aldosterone-insensitive sites during sodium loading than
in the normal subjects excreting similar quantities of
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sodium who have low levels of aldosterone. To account for
the hypercalciuria observed, the sites in the distal nephron
wherein adaptation during mineralocorticoid escape occurs
must be one at which sodium and calcium reabsorption
occur in a closely coupled fashion. This contrasts to the
aldosterone sensitive sites of sodium transport where
sodium reabsorption without calcium can be stimulated by
the hormone [28]. Our data suggest also that in normal sub-
jects, adjustments to dietary sodium loading occur at both
the aldosterone sensitive and insensitive sites, since
natriuresis and calciuria occur in parallel, but the level of
calcium excretion at any level of natriuresis is less than in
hyperaldosteronism. The precise locus in the nephron of the
aldosterone-insensitive sites is not apparent from these kind
of studies, but the ioop of Henle is a likely location since
micropuncture studies have shown that this segment has
the capacity to reabsorb appreciable amounts of calcium as
well as sodium [12].
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